249 related articles for article (PubMed ID: 28314120)
21. The hypotensive effect of activated apelin receptor is correlated with β-arrestin recruitment.
Besserer-Offroy É; Bérubé P; Côté J; Murza A; Longpré JM; Dumaine R; Lesur O; Auger-Messier M; Leduc R; Marsault É; Sarret P
Pharmacol Res; 2018 May; 131():7-16. PubMed ID: 29530600
[TBL] [Abstract][Full Text] [Related]
22. G protein-coupled receptor kinases (GRKs) orchestrate biased agonism at the β
Choi M; Staus DP; Wingler LM; Ahn S; Pani B; Capel WD; Lefkowitz RJ
Sci Signal; 2018 Aug; 11(544):. PubMed ID: 30131371
[TBL] [Abstract][Full Text] [Related]
23. Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.
Free RB; Chun LS; Moritz AE; Miller BN; Doyle TB; Conroy JL; Padron A; Meade JA; Xiao J; Hu X; Dulcey AE; Han Y; Duan L; Titus S; Bryant-Genevier M; Barnaeva E; Ferrer M; Javitch JA; Beuming T; Shi L; Southall NT; Marugan JJ; Sibley DR
Mol Pharmacol; 2014 Jul; 86(1):96-105. PubMed ID: 24755247
[TBL] [Abstract][Full Text] [Related]
24. Characterization of structurally novel G protein biased CB
Ford BM; Franks LN; Tai S; Fantegrossi WE; Stahl EL; Berquist MD; Cabanlong CV; Wilson CD; Penthala NR; Crooks PA; Prather PL
Pharmacol Res; 2017 Nov; 125(Pt B):161-177. PubMed ID: 28838808
[TBL] [Abstract][Full Text] [Related]
25. [Biased Signaling through G Protein-coupled Receptors].
Kurose H
Yakugaku Zasshi; 2022; 142(10):1091-1101. PubMed ID: 36184444
[TBL] [Abstract][Full Text] [Related]
26. Apelin receptor homodimer-oligomers revealed by single-molecule imaging and novel G protein-dependent signaling.
Cai X; Bai B; Zhang R; Wang C; Chen J
Sci Rep; 2017 Jan; 7():40335. PubMed ID: 28091541
[TBL] [Abstract][Full Text] [Related]
27. Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJ.
Myers MC; Bilder DM; Cavallaro CL; Chao HJ; Su S; Burford NT; Nayeem A; Wang T; Yan M; Langish RA; Dabros M; Li YX; Rose AV; Behnia K; Onorato JM; Gargalovic PS; Wexler RR; Lawrence RM
Bioorg Med Chem Lett; 2020 Apr; 30(7):126955. PubMed ID: 32035698
[TBL] [Abstract][Full Text] [Related]
28. Biased agonists of the chemokine receptor CXCR3 differentially signal through Gα
Zheng K; Smith JS; Eiger DS; Warman A; Choi I; Honeycutt CC; Boldizsar N; Gundry JN; Pack TF; Inoue A; Caron MG; Rajagopal S
Sci Signal; 2022 Mar; 15(726):eabg5203. PubMed ID: 35316095
[TBL] [Abstract][Full Text] [Related]
29. Cardiac action of the first G protein biased small molecule apelin agonist.
Read C; Fitzpatrick CM; Yang P; Kuc RE; Maguire JJ; Glen RC; Foster RE; Davenport AP
Biochem Pharmacol; 2016 Sep; 116():63-72. PubMed ID: 27475715
[TBL] [Abstract][Full Text] [Related]
30. The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles.
Jiang Y; Yan M; Wang C; Wang Q; Chen X; Zhang R; Wan L; Ji B; Dong B; Wang H; Chen J
Front Pharmacol; 2021; 12():630548. PubMed ID: 33746758
[TBL] [Abstract][Full Text] [Related]
31. Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling.
Deng C; Chen H; Yang N; Feng Y; Hsueh AJ
J Biol Chem; 2015 Jul; 290(30):18261-8. PubMed ID: 25995451
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationship of novel macrocyclic biased apelin receptor agonists.
Murza A; Sainsily X; Côté J; Bruneau-Cossette L; Besserer-Offroy É; Longpré JM; Leduc R; Dumaine R; Lesur O; Auger-Messier M; Sarret P; Marsault É
Org Biomol Chem; 2017 Jan; 15(2):449-458. PubMed ID: 27924341
[TBL] [Abstract][Full Text] [Related]
33. Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist.
Brame AL; Maguire JJ; Yang P; Dyson A; Torella R; Cheriyan J; Singer M; Glen RC; Wilkinson IB; Davenport AP
Hypertension; 2015 Apr; 65(4):834-40. PubMed ID: 25712721
[TBL] [Abstract][Full Text] [Related]
34. β
De Pascali F; Ippolito M; Wolfe E; Komolov KE; Hopfinger N; Lemenze D; Kim N; Armen RS; An SS; Scott CP; Benovic JL
Br J Pharmacol; 2022 Oct; 179(19):4692-4708. PubMed ID: 35732075
[TBL] [Abstract][Full Text] [Related]
35. Allosteric coupling and biased agonism in G protein-coupled receptors.
Bock A; Bermudez M
FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
[TBL] [Abstract][Full Text] [Related]
36. Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α(2C) receptor.
Kurko D; Kapui Z; Nagy J; Lendvai B; Kolok S
Brain Res Bull; 2014 Aug; 107():89-101. PubMed ID: 25080296
[TBL] [Abstract][Full Text] [Related]
37. Structure-based design of non-hypertrophic apelin receptor modulator.
Wang WW; Ji SY; Zhang W; Zhang J; Cai C; Hu R; Zang SK; Miao L; Xu H; Chen LN; Yang Z; Guo J; Qin J; Shen DD; Liang P; Zhang Y; Zhang Y
Cell; 2024 Mar; 187(6):1460-1475.e20. PubMed ID: 38428423
[TBL] [Abstract][Full Text] [Related]
38. High-throughput identification and characterization of novel, species-selective GPR35 agonists.
Neetoo-Isseljee Z; MacKenzie AE; Southern C; Jerman J; McIver EG; Harries N; Taylor DL; Milligan G
J Pharmacol Exp Ther; 2013 Mar; 344(3):568-78. PubMed ID: 23262279
[TBL] [Abstract][Full Text] [Related]
39. Comparative Study of Elabela and Apelin on Apelin Receptor Activation Through β-Arrestin Recruitment.
Zhang H; Chen J; Shi M; Xu F; Zhang X; Gong DW
Mol Biotechnol; 2023 Mar; 65(3):394-400. PubMed ID: 35960440
[TBL] [Abstract][Full Text] [Related]
40. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
